Trevor K. Rogers

Learn More
BACKGROUND Poor U.K. lung cancer survival rates may, in part, be due to late diagnosis. OBJECTIVES To evaluate the effectiveness of a mixed-method community-based social marketing intervention on lung cancer diagnoses. METHODS A public awareness campaign in conjunction with brief intervention training in general practices was piloted in six localities(More)
BACKGROUND The UK has poor lung cancer survival rates and high early mortality, compared to other countries. We aimed to identify factors associated with early death, and features of primary care that might contribute to late diagnosis. METHODS All cases of lung cancer diagnosed between 2000 and 2013 were extracted from The Health Improvement Network(More)
Finding an abnormality on a plain chest radiograph is usually the first definite evidence of a lung cancer, so this investigation is currently pivotal in the diagnosis of the disease. Although the National Institute for Clinical Excellence (NICE) has produced guidance on when a chest radiograph should be done for putative lung cancer presentations, cancer(More)
Aims. We have audited the changes in treatment practice for small-cell lung cancer (SCLC) presented to a single multidisciplinary team (MDT) at Doncaster and Bassetlaw Hospitals between January 1998 and December 2005. Materials and Methods. The MDT database was used to identify all patients with SCLC. Anonymised demographic, treatment, and outcome details(More)
one copy of any article(s) in SHURA to facilitate their private study or for non-commercial research. You may not engage in further distribution of the material or use it for any profit-making activities or any commercial gain. Abstract Lung cancer is a major global health burden with high incidence rates but poor long-term survival. Currently the majority(More)
BACKGROUND In order to improve lung cancer survival in the UK, a greater proportion of resectable cancers must be diagnosed. It is likely that resectability rates would be increased by more timely diagnosis. Aside from screening, the only way of achieving this is to reduce the time to diagnosis in symptomatic cancers. Currently, lung cancers are mainly(More)
  • 1